ENTRY       D10286            Mixture   Drug
NAME        Amlodipine, valsartan and hydrochlorothiazide;
            Exforge hct (TN)
PRODUCT     EXFORGE HCT (Novartis Pharmaceuticals Corporation)
  GENERIC   AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE (Aurobindo Pharma Limited)
            AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE (Golden State Medical Supply)
            AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE (Strides Pharma Science Limited)
COMPONENT   Amlodipine besilate [DR:D00615], Hydrochlorothiazide [DR:D00340], Valsartan [DR:D00400]
CLASS       Cardiovascular agent
             DG01925  Renin-angiotensin system inhibitor
             DG03231  Antihypertensive
REMARK      ATC code: C09DX01
            Product: D10286<US>
EFFICACY    Antihypertensive
  DISEASE   Hypertension [DS:H01633]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
               C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
                C09DX Angiotensin II receptor blockers (ARBs), other combinations
                 C09DX01 Valsartan, amlodipine and hydrochlorothiazide
                  D10286  Amlodipine, valsartan and hydrochlorothiazide &lt;US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Cardiovascular Combinations
               Amlodipine/ Valsartan/ Hydrochlorothiazide
                D10286  Amlodipine, valsartan and hydrochlorothiazide
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01925  Renin-angiotensin system inhibitor
               D10286  Amlodipine, valsartan and hydrochlorothiazide
              DG03231  Antihypertensive
               D10286  Amlodipine, valsartan and hydrochlorothiazide
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D10286  Amlodipine, valsartan and hydrochlorothiazide
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10286
DBLINKS     PubChem: 163312317
///
